NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Amgen (AMGN - Get Report) was upgraded at Goldman Sachs to buy from neutral. $130 price target. Company was also added to the Conviction Buy List, as the company has multiple potential catalysts, Goldman said.
CapitalSource (CSE) was downgraded to hold at TheStreet Ratings.Dreamworks (DWA - Get Report) was upgraded at Bank of America/Merrill Lynch to neutral. $22 price target. Company appears to be at a positive inflection point, BofA/Merrill said. Freeport-McMoran (FCX - Get Report) was upgraded at Nomura to buy from neutral. $38 price target. Company prices appear oversold, and valuation multiples should expand, Nomura said. Fiserv (FISV) was downgraded at Oppenheimer to perform from outperform. Valuation call, based on an $89 price target, Oppenheimer said.
LSI (LSI) was downgraded at Goldman Sachs to neutral from buy. $7 price target. Company is leveraged to weak enterprise spending and lower PC demand, Goldman Sachs said. Nuance (NUAN) was downgraded at Morgan Stanley to equal-weight. Company is facing increased growth risks, Morgan Stanley said. Oil States (OIS) was downgraded at BMO Capital to underperform. Valuation call, based on an $82 price target, BMO Capital said. Oneok (OKE) was downgraded at Morgan Stanley to equal-weight. $53 price target. Stock is up 20% year to date, despite deteriorating fundamentals, Morgan Stanley said. Opko Health (OPK) was downgraded to hold at TheStreet Ratings.
Ultimate Software (ULTI - Get Report) was upgraded at Canaccord Genuity to buy. $110 price target. Company is carrying a lot of momentum into the new year, Canaccord said. STOCK COMMENTS/EPS CHANGES Aetna (AET) estimates, price target were raised at BMO Capital. Shares are now seen reaching $64. Estimates were also increased, given improving core trends, BMO Capital said. Outperform rating. Artisan Partners Asset Management (APAM) price target and estimates were increased at Citigroup. Solid flows, underlying margin dynamics and favorable FCF, said Citigroup. Price target goes to $47. Avon (AVP) estimates, price target were boosted at BMO Capital. Shares are now seen reaching $27. Estimates were also increased, as the company is realizing higher margins, BMO Capital said. Outperform rating.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts